Literature DB >> 9060831

Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients.

S Uccini1, M C Sirianni, L Vincenzi, S Topino, A Stoppacciaro, I Lesnoni La Parola, M Capuano, C Masini, D Cerimele, M Cella, A Lanzavecchia, P Allavena, A Mantovani, C D Baroni, L P Ruco.   

Abstract

The mannose receptor (MR) is a surface 175-kd C-type lectin expressed by macrophages and dendritic cells. MR is involved in removal of effete cells, phagocytosis of mannose-coated particles, pinocytosis, and antigen presentation. Expression of MR was investigated in 17 biopsies of Kaposi's sarcoma (3 AIDS KS, 13 classical KS, and 1 transplant-associated KS) using three anti-MR monoclonal antibodies (3.29, D547, and PAM1). Immunostaining for MR was detected in 94 +/- 7% KS cells with spindle morphology. In normal tissues, MR was expressed by sinus-lining cells of spleen and lymph nodes, but it was not detected in endothelial cells lining normal hematic and lymphatic vessels, hemangioma, hemangioendothelioma, and lymphangioma. Expression of MR in KS cells prompted us to investigate the possibility that they derive from a circulating precursor cell. Peripheral blood mononuclear cells from 16 patients with KS (10 classical, 1 transplanted, and 5 AIDS) were cultured in PHA-conditioned medium for 10 to 14 days. Confluent monolayers of adherent spindle cells were detected in 8 of 11 classical KS, in 5 of 5 AIDS KS patients, and in 0 of 34 control patients. Peripheral-blood-derived KS-like cells were characterized by co-expression of macrophage and endothelial antigens being positive for CD45 (60%), CD68 (98%), MR (70%), CD14 (25%), VE-cadherin (70%), and von Willebrand factor (10%). When the immunophenotype of peripheral-blood-derived adherent cells was compared with that of KS spindle cells of tissue biopsies, it was found that both cell types are VE-cadherin+/MR+/CD68+, that peripheral-blood-derived spindle cells are CD34- and are less frequently stained for CD31 and von Willebrand factor, and that lesional KS cells do not express the leukocyte markers CD45 and CD18. Our findings are consistent with the possibility that KS lesions derive from tissue accumulation and local proliferation of a special subset of macrophages with endothelial features the normal counterpart of which are the sinus-lining cells of spleen and lymph nodes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9060831      PMCID: PMC1857876     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  Histogenesis of Kaposi's sarcoma in patients with and without acquired immune deficiency syndrome (AIDS).

Authors:  R R Jones; J Spaull; C Spry; E W Jones
Journal:  J Clin Pathol       Date:  1986-07       Impact factor: 3.411

2.  The spindle-shaped cells in cutaneous Kaposi's sarcoma. Histologic simulators include factor XIIIa dermal dendrocytes.

Authors:  B J Nickoloff; C E Griffiths
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

3.  AIDS-related Kaposi's sarcoma displays differential expression of endothelial surface antigens.

Authors:  P A Scully; H K Steinman; C Kennedy; K Trueblood; D M Frisman; J R Voland
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

4.  Evidence for the origin of Kaposi's sarcoma from lymphatic endothelium.

Authors:  J H Beckstead; G S Wood; V Fletcher
Journal:  Am J Pathol       Date:  1985-05       Impact factor: 4.307

5.  Immunohistochemical heterogeneity of macrophage subpopulations in human lymphoid tissues.

Authors:  C D Baroni; D Vitolo; D Remotti; A Biondi; F Pezzella; L P Ruco; S Uccini
Journal:  Histopathology       Date:  1987-10       Impact factor: 5.087

6.  The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma. Evidence for a vascular endothelial cell origin.

Authors:  J L Rutgers; R Wieczorek; F Bonetti; K L Kaplan; D N Posnett; A E Friedman-Kien; D M Knowles
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

7.  Human splenic sinusoidal lining cells express antigens associated with monocytes, macrophages, endothelial cells, and T lymphocytes.

Authors:  P J Buckley; S A Dickson; W S Walker
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

8.  Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor.

Authors:  R A Ezekowitz; D J Williams; H Koziel; M Y Armstrong; A Warner; F F Richards; R M Rose
Journal:  Nature       Date:  1991-05-09       Impact factor: 49.962

9.  Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells.

Authors:  C Boshoff; T F Schulz; M M Kennedy; A K Graham; C Fisher; A Thomas; J O McGee; R A Weiss; J J O'Leary
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

10.  Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.

Authors:  F Sallusto; M Cella; C Danieli; A Lanzavecchia
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  17 in total

1.  Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells.

Authors:  P Monini; F Carlini; M Stürzl; P Rimessi; F Superti; M Franco; G Melucci-Vigo; A Cafaro; D Goletti; C Sgadari; S Butto'; P Leone; C Chiozzini; C Barresi; A Tinari; A Bonaccorsi; M R Capobianchi; M Giuliani; A di Carlo; M Andreoni; G Rezza; B Ensoli
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Platelet-activating factor regulates cadherin-catenin adhesion system expression and beta-catenin phosphorylation during Kaposi's sarcoma cell motility.

Authors:  Mariarosaria Boccellino; Giovanni Camussi; Alfonso Giovane; Luigi Ferro; Vincenzo Calderaro; Ciro Balestrieri; Lucio Quagliuolo
Journal:  Am J Pathol       Date:  2005-05       Impact factor: 4.307

3.  Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice.

Authors:  Gianna Ballon; Kang Chen; Rocio Perez; Wayne Tam; Ethel Cesarman
Journal:  J Clin Invest       Date:  2011-02-21       Impact factor: 14.808

Review 4.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

Review 5.  Immunosuppressive properties of mesenchymal stem cells.

Authors:  Mohamed Abumaree; Mohammed Al Jumah; Rishika A Pace; Bill Kalionis
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

6.  Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines.

Authors:  P Romagnani; A De Paulis; C Beltrame; F Annunziato; V Dente; E Maggi; S Romagnani; G Marone
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

7.  Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus.

Authors:  Mandana Mansouri; Patrick P Rose; Ashlee V Moses; Klaus Früh
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

8.  Susceptibility of human fetal mesenchymal stem cells to Kaposi sarcoma-associated herpesvirus.

Authors:  Christopher H Parsons; Barbara Szomju; Dean H Kedes
Journal:  Blood       Date:  2004-07-06       Impact factor: 22.113

9.  Characterization of c-Kit expression and activation in KSHV-infected endothelial cells.

Authors:  Janet L Douglas; Jill G Whitford; Ashlee V Moses
Journal:  Virology       Date:  2009-06-06       Impact factor: 3.616

10.  Mannosylated mucin-type immunoglobulin fusion proteins enhance antigen-specific antibody and T lymphocyte responses.

Authors:  Gustaf Ahlén; Lena Strindelius; Tomas Johansson; Anki Nilsson; Nathalie Chatzissavidou; Magnus Sjöblom; Ulrika Rova; Jan Holgersson
Journal:  PLoS One       Date:  2012-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.